Stock listing
Neurocrine Biosciences, Inc.
Selected listing: 900964 · LS · EUR · DE
Neurocrine Biosciences, Inc. (Lang & Schwarz: 900964), Health Technology. Latest release Sep 30, 2026: Neurocrine Biosciences to Present Research Advancing…
- Ticker
- Lang & Schwarz: 900964
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. The company is committed to advancing innovative therapies to improve patient outcomes.
Latest news from Neurocrine Biosciences, Inc.
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
September 30, 2026
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
September 29, 2026
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
September 28, 2026
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia
August 12, 2026
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
August 7, 2026
Events
Research Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. company profile
View the public company page for Neurocrine Biosciences, Inc. on 6ix.
Neurocrine Biosciences, Inc. news
Read company news and market updates connected to Neurocrine Biosciences, Inc..
Neurocrine Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Neurocrine Biosciences, Inc..
Alternate listings
NBIX:NASDAQ
US · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NB3:GETTEX
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NB3:FWB
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
900964:LSX
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NBIX:BMV
MX · MXN
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
0K6R:LSE
GB · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
N1BI34:BMFBOVESPA
BR · BRL
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NB3:TRADEGATE
DE · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
1NBIX:MIL
IT · EUR
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NBIX:BIVA
MX · MXN
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NBIX:BOATS
US · USD
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.
NB3:BX
CH · CHF
Alternate listing for Neurocrine Biosciences, Inc.; the primary context on this page is 900964:LS.